The largest database of trusted experimental protocols

11 protocols using alt r genome editing detection kit

1

CRISPR-Cas9 Genome Editing in HEK293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid-based genome editing experiments in HEK293 cells were performed with 0.5 μL per well TransiT-X2® (Mirus Bio, Madison, WI, USA) lipid transfection reagent, 0.1 μg per well Cas9 human expression plasmid, and 30 nM 1:1 (crRNA:tracrRNA) Alt-R® (Integrated DNA Technologies, Inc) gRNA complex prepared in a volume of 50 μL total using Opti-MEM™ reduced serum media (Thermo Fisher Scientific) according to the manufacturer’s specifications. Transfections were performed in 96-well plates with 50,000 HEK293 cells in a total volume of 150 μL using DMEM with 10% FBS, and DNA was extracted 48 hrs post-transfection using QuickExtract™ DNA extraction solution (Epicentre Biotechnologies, Madison, WI, USA) according to the manufacturer’s specifications. Mutation detection was performed (unless otherwise indicated) with T7 Endonuclease I using the Alt-R® Genome Editing Detection Kit (Integrated DNA Technologies, Inc) according to the manufacturer’s instructions. For the T7EI assays, both “cells only” and “no gRNA” controls were performed for every experiment to assess background levels of INDELs. Our T7EI experiments were performed only with amplicons that gave no detectable background under these conditions. The targeting sequence for each Cas9 crRNA is listed in Supplementary Table 4.
+ Open protocol
+ Expand
2

Screening T1 Plants for CRISPR Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
T1 plants were screened for mutations using a T7 endonuclease 1 (T7E1) assay. DNA was extracted from 3-week-old T1 plants by heating a 1 mm leaf disk in 25 μL Extract-N-Amp extraction solution (E7526) at 95 °C for 10 minutes and then adding 25 μL PCR Diluent (E8155, MilliporeSigma, St. Louis, MO). Primers were selected to amplify an approximately 1000 bp region flanking the Cas9 target site (Supplemental Table S1). PCR was carried out using Phire Green Hot Start II Mastermix (ThermoFisher Scientific, Waltham, MA) under manufacturer-recommended conditions. For the T7E1 assay, the Alt-R Genome Editing Detection Kit (Integrated DNA Technologies, Coralville, IA) was used according to manufacturer specifications. In any samples with the presence of non-wildtype amplicons, PCR products were purified (Wizard SV Gel and PCR Clean-Up System, Promega Corporation, Madison, WI) and sent for Sanger sequencing at the Cornell Biotechnology Resource Center (Cornell University, Ithaca, NY). T2 seeds collected from plants with confirmed target site mutations were screened for the absence of fluorescence and the presence of a homozygous mutation at the target site using Sanger sequencing. T3 seeds collected from these non-transgenic, homozygous mutant plants were used for further analyses.
+ Open protocol
+ Expand
3

Generation of ELF3 Knockout Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
An ELF3 gene knockout clone was obtained using the Alt‐R CRISPR/Cas9‐system (Integrated DNA Technologies) according to the manufacturer's instructions. The complex comprising two‐part guide RNA, crRNA, and transactivating crRNA (tracrRNA) targeting the ELF3 sequence (GGACTGGATCAGCTACCAAGTGG) and Cas9 nuclease were transfected into cells using lipofectamine for ECC4 cells or electroporation for A99 cells, as described in the siRNA section. The limiting dilution cloning method was applied for the establishment of gene knockout clones. DNA of each clone was extracted using the QIAamp DNA Mini Kit (Qiagen), and genome editing was confirmed using the Alt‐R® Genome Editing Detection Kit (Integrated DNA Technologies) and Sanger sequencing.
+ Open protocol
+ Expand
4

CRISPR Mutation Detection in MYOC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated using NucleoSpin Tissue (catalog# 740952, Macherey-Nagel, Allentown, PA, USA) from cells treated with LV_crMYOC, AAV2_crMYOC, LV_Null and AAV2_Null. Untreated cells were used as experimental control. MYOC, which is a target of selected gRNA was amplified by PCR. PCR product was denatured and reannealed using the Alt-R Genome Editing Detection Kit protocol (catalog# 1075932, Integrated DNA Technologies, Coralville, Iowa, USA). This generated mismatched heteroduplex DNA products containing strands with CRISPR/Cas9-induced indel reannealed to wild-type strands or different indel. The heteroduplexes were subsequently detected using T7 endonucleases (T7E1), that cleaved the mismatched DNA. The resulting cleaved products were analyzed by gel electrophoresis.
+ Open protocol
+ Expand
5

CRISPR-Cas9 Genome Editing in HEK293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid-based genome editing experiments in HEK293 cells were performed with 0.5 μL per well TransiT-X2® (Mirus Bio, Madison, WI, USA) lipid transfection reagent, 0.1 μg per well Cas9 human expression plasmid, and 30 nM 1:1 (crRNA:tracrRNA) Alt-R® (Integrated DNA Technologies, Inc) gRNA complex prepared in a volume of 50 μL total using Opti-MEM™ reduced serum media (Thermo Fisher Scientific) according to the manufacturer’s specifications. Transfections were performed in 96-well plates with 50,000 HEK293 cells in a total volume of 150 μL using DMEM with 10% FBS, and DNA was extracted 48 hrs post-transfection using QuickExtract™ DNA extraction solution (Epicentre Biotechnologies, Madison, WI, USA) according to the manufacturer’s specifications. Mutation detection was performed (unless otherwise indicated) with T7 Endonuclease I using the Alt-R® Genome Editing Detection Kit (Integrated DNA Technologies, Inc) according to the manufacturer’s instructions. For the T7EI assays, both “cells only” and “no gRNA” controls were performed for every experiment to assess background levels of INDELs. Our T7EI experiments were performed only with amplicons that gave no detectable background under these conditions. The targeting sequence for each Cas9 crRNA is listed in Supplementary Table 4.
+ Open protocol
+ Expand
6

Detecting Mutagenesis in Euglena gracilis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the detection of mutagenesis at target sites in each Cas12a RNP‐introduced E. gracilis, a T7 Endonuclease I (T7EI) assay was performed using an Alt‐R Genome Editing Detection Kit (Integrated DNA Technologies). Genomic DNA template from E. gracilis was extracted using a Kaneka Easy DNA Extraction Kit version 2 (KANEKA, Tokyo, Japan). DNA fragments including the EgGSL2 target sites were amplified with Tks Gflex DNA Polymerase (Takara Bio, Shiga, Japan) using the EgGSL2 Check F‐R primer set (Table S1). T7EI treatment was carried out according to the manufacturer's protocol using the amplified DNA fragments. Digested DNA fragments were analysed by agarose gel electrophoresis.
+ Open protocol
+ Expand
7

Detecting NHEJ-mediated Genome Editing via T7EI Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect the mutation resulting from DSB repair through the NHEJ pathway, a T7E1 assay was performed as described previously [23 (link)]. T7EI assay detect on-target genome editing and estimate editing efficiency using T7 endonuclease I (T7EI), which can cleave a heteroduplex DNA having mutation in any strand. In the T7EI assay, CRISPR-induced mutant gene is amplified by PCR. The PCR products are denatured and reannealed to allow heteroduplex formation between wild-type DNA and CRISPR–mutated DNA. Mutations are then detected using T7EI, which recognizes and cleaves mismatched DNA heteroduplexes. T7EI assay results are analyzed by visualizing cleavage products and full-length amplicons by gel electrophoresis. In this study genomic DNA was isolated from ChiLCV-challenged plants treated either with gRNA-Cas9 or with mock vector (control) samples collected at 4 dpi and was used as the template for PCR using primers ChiLCV-C1/V1q F and ChiLCV-IR R (Table 1). Amplicons of the ChiLCV genomic fragment obtained from those samples were denatured, renatured, and treated with T7EI using the Alt-R Genome Editing Detection Kit (Integrated DNA Technologies) following the manufacturer’s protocol. Results were evaluated using agarose gel electrophoresis. A control heteroduplex DNA sample provided in the kit served as positive control for the assay.
+ Open protocol
+ Expand
8

Screening T1 Plants for CRISPR Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
T1 plants were screened for mutations using a T7 endonuclease 1 (T7E1) assay. DNA was extracted from 3-week-old T1 plants by heating a 1 mm leaf disk in 25 μL Extract-N-Amp extraction solution (E7526) at 95 °C for 10 minutes and then adding 25 μL PCR Diluent (E8155, MilliporeSigma, St. Louis, MO). Primers were selected to amplify an approximately 1000 bp region flanking the Cas9 target site (Supplemental Table S1). PCR was carried out using Phire Green Hot Start II Mastermix (ThermoFisher Scientific, Waltham, MA) under manufacturer-recommended conditions. For the T7E1 assay, the Alt-R Genome Editing Detection Kit (Integrated DNA Technologies, Coralville, IA) was used according to manufacturer specifications. In any samples with the presence of non-wildtype amplicons, PCR products were purified (Wizard SV Gel and PCR Clean-Up System, Promega Corporation, Madison, WI) and sent for Sanger sequencing at the Cornell Biotechnology Resource Center (Cornell University, Ithaca, NY). T2 seeds collected from plants with confirmed target site mutations were screened for the absence of fluorescence and the presence of a homozygous mutation at the target site using Sanger sequencing. T3 seeds collected from these non-transgenic, homozygous mutant plants were used for further analyses.
+ Open protocol
+ Expand
9

Amplification and Analysis of Prion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prnp fragments were amplified using AccuPrime Taq DNA Polymerase, High Fidelity (Invitrogen, LS12346086; see S1 Table for primer sequences). After agarose gel electrophoresis, DNA concentrations were estimated by comparison to the GeneRuler 1 kb Plus DNA Ladder; band intensities were quantified using ImageJ. Hybridization and T7E1 incubation steps were performed according to the Alt-R Genome Editing Detection Kit instructions (Integrated DNA Technologies, 1075931), except that incubation with T7E1 was shortened to 30 min. Reactions were stopped by addition of EDTA to ~25 mM.
+ Open protocol
+ Expand
10

CRISPR Off-Target Site Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Off-target sites were predicted utilizing the Optimized CRISPR Design (http://crispor.tefor.net) and (https://design.synthego.com). Loci of predicted sites with highest scores were PCR amplified from gDNA of PLB-985 WT and clones of S200Cfs7* and G81Vfs27* NOX2 PLB-985 cells using specific primers (Supplementary Tables 1S and2S) for presence of insertions or deletions (indels). Corresponding PCR amplification products (from WT PLB-985 cells and CYBB KO PLB-985 cells) were mixed in a ratio of 1:1 (Supplementary Fig. 3S). Alt-R Controls A and B are positive controls that each contain templates and PCR primers for monitoring the function of the T7EI assay. Full length PCR products from controls A and B are identical, except the presence of a 6pb deletion in control B. The samples were denatured at 95 °C for 10 min, slowly renatured, and digested using Alt-R ® Genome Editing Detection Kit (Integrated DNA Technologies, Inc., Coralville, USA) according to the manufacturer's instructions. In none of the potential off-target sites, indels were observed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!